Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.

Roberts, I; Belli, A; Brenner, A; Chaudhri, R; Fawole, B; Harris, T; Jooma, R; Mahmood, A; Shokunbi, T; Shakur, H; +1 more... CRASH-3 trial collaborators; (2018) Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Wellcome open research, 3. p. 86. ISSN 2398-502X DOI: https://doi.org/10.12688/wellcomeopenres.14700.1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.12688/wellcomeopenres.14700.1

Abstract

Share

Download

Filename: Roberts_etal_2018_Tranexamic acid.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar